{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:24:14Z","timestamp":1790418254104,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T00:00:00Z","timestamp":1231891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/npp.2008.227","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T15:07:42Z","timestamp":1231945662000},"page":"1695-1709","source":"Crossref","is-referenced-by-count":25,"title":["Imaging Elevated Brain Arachidonic Acid Signaling in Unanesthetized Serotonin Transporter (5-HTT)-Deficient Mice"],"prefix":"10.1038","volume":"34","author":[{"given":"Mireille","family":"Basselin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dede","family":"Greenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley I","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,14]]},"reference":[{"key":"BFnpp2008227_CR1","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1523\/JNEUROSCI.5156-05.2006","volume":"26","author":"C Alexandre","year":"2006","unstructured":"Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch KP et al (2006). Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci 26: 5554\u20135564.","journal-title":"J Neurosci"},{"key":"BFnpp2008227_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0090-6980(83)90177-6","volume":"26","author":"RF Anton","year":"1983","unstructured":"Anton RF, Wallis C, Randall CL (1983). In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins 26: 421\u2013429.","journal-title":"Prostaglandins"},{"key":"BFnpp2008227_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.pnpbp.2006.10.016","volume":"31","author":"E Baca-Garcia","year":"2007","unstructured":"Baca-Garcia E, Vaquero-Lorenzo C, Diaz-Hernandez M, Rodriguez-Salgado B, Dolengevich-Segal H, Arrojo-Romero M et al (2007). Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Prog Neuropsychopharmacol Biol Psychiatry 31: 416\u2013420.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2008227_CR4","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/sj.npp.1300920","volume":"31","author":"M Basselin","year":"2006","unstructured":"Basselin M, Chang L, Bell JM, Rapoport SI (2006a). Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31: 1659\u20131674.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008227_CR5","unstructured":"Basselin M, Murphy DL, Rapoport SI (2007a). Increased brain arachidonic acid signaling can be imaged in vivo in serotonin transporter deficient mice: Basis for future clinical PET studies (abstract). Annual Meeting American College Neuropsychopharmacology, Boca Ratan, FL. 9\u201313 December 2007 Poster Session III Poster 123."},{"key":"BFnpp2008227_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopsych.2007.04.021","volume":"62","author":"M Basselin","year":"2007","unstructured":"Basselin M, Villacreses NE, Chen M, Bell JM, Rapoport SI (2007b). Chronic carbamazepine administration reduces NMDA receptor-initiated signaling via arachidonic acid in rat brain. Biol Psychiatry 62: 934\u2013943.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2008227_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1471-4159.2005.03612.x","volume":"96","author":"M Basselin","year":"2006","unstructured":"Basselin M, Villacreses NE, Langenbach R, Ma K, Bell JM, Rapoport SI (2006b). Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mouse. J Neurochem 96: 669\u2013679.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/mol.53.4.649","volume":"53","author":"D Bengel","year":"1998","unstructured":"Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A et al (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (\u2018Ecstasy\u2019) in serotonin transporter-deficient mice. Mol Pharmacol 53: 649\u2013655.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2008227_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1749-6632.1998.tb10180.x","volume":"861","author":"KA Berg","year":"1998","unstructured":"Berg KA, Maayani S, Goldfarb J, Clarke WP (1998a). Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists. Ann N Y Acad Sci 861: 104\u2013110.","journal-title":"Ann N Y Acad Sci"},{"key":"BFnpp2008227_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1124\/mol.54.1.94","volume":"54","author":"KA Berg","year":"1998","unstructured":"Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP (1998b). Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54: 94\u2013104.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2008227_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1471-4159.2007.04558.x","volume":"102","author":"F Bosetti","year":"2007","unstructured":"Bosetti F (2007). Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models. J Neurochem 102: 577\u2013586.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/j.1471-4159.2004.02829.x","volume":"91","author":"F Bosetti","year":"2004","unstructured":"Bosetti F, Langenbach R, Weerasinghe GR (2004). Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2 . J Neurochem 91: 1389\u20131397.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR13","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1046\/j.1471-4159.2003.02118.x","volume":"87","author":"F Bosetti","year":"2003","unstructured":"Bosetti F, Weerasinghe GR (2003). The expression of brain cyclooxygenase-2 is down-regulated in the cytosolic phospholipase A2 knockout mouse. J Neurochem 87: 1471\u20131477.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","volume":"301","author":"A Caspi","year":"2003","unstructured":"Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386\u2013389.","journal-title":"Science"},{"key":"BFnpp2008227_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.2042-7158.1993.tb05578.x","volume":"45","author":"R Cesana","year":"1993","unstructured":"Cesana R, Ceci A, Ciprandi C, Borsini F (1993). Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice. J Pharm Pharmacol 45: 473\u2013475.","journal-title":"J Pharm Pharmacol"},{"key":"BFnpp2008227_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0006-8993(97)00088-7","volume":"755","author":"MC Chang","year":"1997","unstructured":"Chang MC, Arai T, Freed LM, Wakabayashi S, Channing MA, Dunn BB et al (1997). Brain incorporation of [1-11C]-arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography. Brain Res 755: 74\u201383.","journal-title":"Brain Res"},{"key":"BFnpp2008227_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0929-7855(95)00012-F","volume":"12","author":"JD Clark","year":"1995","unstructured":"Clark JD, Schievella AR, Nalefski EA, Lin LL (1995). Cytosolic phospholipase A2 . J Lipid Mediat Cell Signal 12: 83\u2013117.","journal-title":"J Lipid Mediat Cell Signal"},{"key":"BFnpp2008227_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.bbalip.2006.06.006","volume":"1761","author":"JC Demar Jr","year":"2006","unstructured":"Demar Jr JC, Lee HJ, Ma K, Chang L, Bell JM, Rapoport SI et al (2006). Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim Biophys Acta 1761: 1050\u20131059.","journal-title":"Biochim Biophys Acta"},{"key":"BFnpp2008227_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1471-4159.2005.03258.x","volume":"94","author":"JC Demar Jr","year":"2005","unstructured":"Demar Jr JC, Ma K, Chang L, Bell JM, Rapoport SI (2005). alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J Neurochem 94: 1063\u20131076.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR20","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1073\/pnas.0501509102","volume":"102","author":"T Esaki","year":"2005","unstructured":"Esaki T, Cook M, Shimoji K, Murphy DL, Sokoloff L, Holmes A (2005). Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci USA 102: 5582\u20135587.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2008227_CR21","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2967\/jnumed.107.049619","volume":"49","author":"G Esposito","year":"2008","unstructured":"Esposito G, Giovacchini G, Liow J-S, Bhattacharjee AK, Greenstein D, Schapiro M et al (2008). Imaging neuroinflammation in Alzheimer disease with radiolabeled arachidonic acid and PET. J Nucl Med 49: 1414\u20131421.","journal-title":"J Nucl Med"},{"key":"BFnpp2008227_CR22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1073\/pnas.87.6.2187","volume":"87","author":"CC Felder","year":"1990","unstructured":"Felder CC, Kanterman RY, Ma AL, Axelrod J (1990). Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci USA 87: 2187\u20132191.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2008227_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1172\/JCI13241","volume":"107","author":"F Fitzpatrick","year":"2001","unstructured":"Fitzpatrick F, Soberman R (2001). Regulated formation of eicosanoids. J Clin Invest 107: 1347\u20131351.","journal-title":"J Clin Invest"},{"key":"BFnpp2008227_CR24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497\u2013509.","journal-title":"J Biol Chem"},{"key":"BFnpp2008227_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00213-007-0910-0","volume":"195","author":"MA Fox","year":"2007","unstructured":"Fox MA, Andrews AM, Wendland JR, Lesch K-P, Holmes A, Murphy DL (2007a). A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berl) 195: 147\u2013166.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008227_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00213-008-1268-7","volume":"201","author":"MA Fox","year":"2008","unstructured":"Fox MA, Jensen CL, French HT, Stein AR, Huang SJ, Tolliver TJ et al (2008a). Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice. Psychopharmacology 201: 203\u2013218.","journal-title":"Psychopharmacology"},{"key":"BFnpp2008227_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.neuropharm.2007.07.009","volume":"53","author":"MA Fox","year":"2007","unstructured":"Fox MA, Jensen CL, Gallagher PS, Murphy DL (2007b). Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology 53: 643\u2013656.","journal-title":"Neuropharmacology"},{"key":"BFnpp2008227_CR28","first-page":"S91","volume":"22","author":"MA Fox","year":"2008","unstructured":"Fox MA, Stein AS, French HT, Murphy DL (2008b). Head twitches in serotonin transporter (SERT)-deficient mice: 5-HT1A and 5-HT2A receptor interactions. Fundam Clin Pharmacol 22: S91.","journal-title":"Fundam Clin Pharmacol"},{"key":"BFnpp2008227_CR29","volume-title":"The Mouse Brain in Stereotaxic Coodinates","author":"KBJ Franklin","year":"1997","unstructured":"Franklin KBJ, Paxinos G (1997). The Mouse Brain in Stereotaxic Coodinates. Academic Press, Inc.: San Diego."},{"key":"BFnpp2008227_CR30","first-page":"1471","volume":"45","author":"G Giovacchini","year":"2004","unstructured":"Giovacchini G, Lerner A, Toczek MT, Fraser C, Ma K, DeMar JC et al (2004). Brain incorporation of [11C]arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J Nucl Med 45: 1471\u20131479.","journal-title":"J Nucl Med"},{"key":"BFnpp2008227_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0024-3205(69)90118-0","volume":"8","author":"LA Gottschalk","year":"1969","unstructured":"Gottschalk LA, Stone WM, Gleser GC, Iacono JM (1969). Anxiety and plasma free fatty acids (FFA). Life Sci 8: 61\u201368.","journal-title":"Life Sci"},{"key":"BFnpp2008227_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/07315724.1986.10720125","volume":"5","author":"RT Holman","year":"1986","unstructured":"Holman RT (1986). Control of polyunsaturated acids in tissue lipids. J Am Coll Nutr 5: 183\u2013211.","journal-title":"J Am Coll Nutr"},{"key":"BFnpp2008227_CR33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.neuroscience.2007.03.030","volume":"146","author":"JR Homberg","year":"2007","unstructured":"Homberg JR, Olivier JD, Smits BM, Mul JD, Mudde J, Verheul M et al (2007). Characterization of the serotonin transporter knockout rat: A selective change in the functioning of the serotonergic system. Neuroscience 146: 1662\u20131676.","journal-title":"Neuroscience"},{"key":"BFnpp2008227_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1086\/503850","volume":"78","author":"XZ Hu","year":"2006","unstructured":"Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78: 815\u2013826.","journal-title":"Am J Hum Genet"},{"key":"BFnpp2008227_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neuropharm.2007.12.001","volume":"54","author":"KA Jennings","year":"2008","unstructured":"Jennings KA, Sheward WJ, Harmar AJ, Sharp T (2008). Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Neuropharmacology 54: 776\u2013783.","journal-title":"Neuropharmacology"},{"key":"BFnpp2008227_CR36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3382\/ps.0661059","volume":"66","author":"TM John","year":"1987","unstructured":"John TM, Viswanathan M, Etches RJ, Pilo B, George JC (1987). Influence of corticosterone infusion on plasma levels of catecholamines, thyroid hormones, and certain metabolites in laying hens. Poult Sci 66: 1059\u20131063.","journal-title":"Poult Sci"},{"key":"BFnpp2008227_CR37","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1073\/pnas.93.6.2317","volume":"93","author":"WE Kaufmann","year":"1996","unstructured":"Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P (1996). COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 93: 2317\u20132321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2008227_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1194\/jlr.M700406-JLR200","volume":"49","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP (2008). Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. J Lipid Res 49: 162\u2013168.","journal-title":"J Lipid Res"},{"key":"BFnpp2008227_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00213-006-0582-1","volume":"190","author":"HJ Lee","year":"2007","unstructured":"Lee HJ, Rao JS, Ertley RN, Chang L, Rapoport SI, Bazinet RP (2007). Chronic fluoxetine increases cytosolic phospholipase A2 activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. Psychopharmacology (Berl) 190: 103\u2013115.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008227_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.mp.4001890","volume":"12","author":"D Li","year":"2007","unstructured":"Li D, He L (2007). Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 12: 47\u201354.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2008227_CR41","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1046\/j.1471-4159.2003.01607.x","volume":"84","author":"Q Li","year":"2003","unstructured":"Li Q, Wichems CH, Ma L, Van de Kar LD, Garcia F, Murphy DL (2003). Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J Neurochem 84: 1256\u20131265.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR42","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0022-3565(25)20792-3","volume":"278","author":"GJ Marek","year":"1996","unstructured":"Marek GJ, Aghajanian GK (1996). LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther 278: 1373\u20131382.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008227_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/01.ypg.0000199449.07786.7d","volume":"16","author":"FZ Marques","year":"2006","unstructured":"Marques FZ, Hutz MH, Bau CH (2006). Influence of the serotonin transporter gene on comorbid disorders among alcohol-dependent individuals. Psychiatr Genet 16: 125\u2013131.","journal-title":"Psychiatr Genet"},{"key":"BFnpp2008227_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.ypg.0000180684.26288.d7","volume":"16","author":"E Masoliver","year":"2006","unstructured":"Masoliver E, Menoyo A, Perez V, Volpini V, Rio ED, Perez J et al (2006). Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder. Psychiatr Genet 16: 25\u201329.","journal-title":"Psychiatr Genet"},{"key":"BFnpp2008227_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jneumeth.2004.05.017","volume":"140","author":"TA Mathews","year":"2004","unstructured":"Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM (2004). Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 140: 169\u2013181.","journal-title":"J Neurosci Methods"},{"key":"BFnpp2008227_CR46","first-page":"82","volume-title":"Prism 4 Statistics Guide-Statistical Analyses for Laboratory and Clinical Researchers","author":"H Motulsky","year":"2003","unstructured":"Motulsky H (2003). Prism 4 Statistics Guide-Statistical Analyses for Laboratory and Clinical Researchers. GraphPad Software Inc.: San Diego, pp 82\u201384."},{"key":"BFnpp2008227_CR47","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.neuropharm.2008.08.034","volume":"55","author":"DL Murphy","year":"2008","unstructured":"Murphy DL, Fox MA, Timpano KR, Moya P, Ren-Patterson R, Andrews AM et al (2008). How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 55: 932\u2013960.","journal-title":"Neuropharmacology"},{"key":"BFnpp2008227_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1124\/mi.4.2.8","volume":"4","author":"DL Murphy","year":"2004","unstructured":"Murphy DL, Lerner A, Rudnick G, Lesch KP (2004). Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 4: 109\u2013123.","journal-title":"Mol Interv"},{"key":"BFnpp2008227_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrn2284","volume":"9","author":"DL Murphy","year":"2008","unstructured":"Murphy DL, Lesch KP (2008). Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 9: 85\u201396.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2008227_CR50","first-page":"391","volume":"39","author":"WY Ong","year":"1999","unstructured":"Ong WY, Sandhya TL, Horrocks LA, Farooqui AA (1999). Distribution of cytoplasmic phospholipase A2 in the normal rat brain. J Hirnforsch 39: 391\u2013400.","journal-title":"J Hirnforsch"},{"key":"BFnpp2008227_CR51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0169-328X(03)00262-6","volume":"116","author":"S Pardue","year":"2003","unstructured":"Pardue S, Rapoport SI, Bosetti F (2003). Co-localization of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey cerebellum. Brain Res Mol Brain Res 116: 106\u2013114.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFnpp2008227_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.biopsych.2006.09.022","volume":"62","author":"N Praschak-Rieder","year":"2007","unstructured":"Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M et al (2007). Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [11C] DASB positron emission tomography study. Biol Psychiatry 62: 327\u2013331.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2008227_CR53","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.euroneuro.2006.01.008","volume":"16","author":"Y Qu","year":"2006","unstructured":"Qu Y, Chang L, Klaff J, Seemann R, Greenstein D, Rapoport SI (2006). Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats. Eur Neuropsychopharmacol 16: 561\u2013571.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2008227_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00213-005-2231-5","volume":"180","author":"Y Qu","year":"2005","unstructured":"Qu Y, Villacreses N, Murphy DL, Rapoport SI (2005). 5-HT2A\/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl) 180: 12\u201320.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008227_CR55","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/j.1471-4159.2007.04648.x","volume":"102","author":"JS Rao","year":"2007","unstructured":"Rao JS, Ertley RN, Rapoport SI, Bazinet RP, Lee H-J (2007). Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J Neurochem 102: 1918\u20131927.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR56","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/mp.2008.31","volume":"13","author":"JS Rao","year":"2008","unstructured":"Rao JS, Lee HJ, Rapoport SI, Bazinet RP (2008). Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry 13: 585\u2013596.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2008227_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/JMN:16:2-3:243","volume":"16","author":"SI Rapoport","year":"2001","unstructured":"Rapoport SI (2001). In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 16: 243\u2013261.","journal-title":"J Mol Neurosci"},{"key":"BFnpp2008227_CR58","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/archpsyc.59.7.592","volume":"59","author":"SI Rapoport","year":"2002","unstructured":"Rapoport SI, Bosetti F (2002). Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch Gen Psychiatry 59: 592\u2013596.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2008227_CR59","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-2275(20)31629-1","volume":"42","author":"SI Rapoport","year":"2001","unstructured":"Rapoport SI, Chang MCJ, Spector AA (2001). Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 42: 678\u2013685.","journal-title":"J Lipid Res"},{"key":"BFnpp2008227_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0165-0173(92)90016-F","volume":"17","author":"PJ Robinson","year":"1992","unstructured":"Robinson PJ, Noronha J, DeGeorge JJ, Freed LM, Nariai T, Rapoport SI (1992). A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: Review and critical analysis. Brain Res Brain Res Rev 17: 187\u2013214.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFnpp2008227_CR61","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","volume":"18","author":"T Rubino","year":"2008","unstructured":"Rubino T, Realini N, Castiglioni C, Guidali C, Vigano D, Marras E et al (2008). Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 18: 1292\u20131301.","journal-title":"Cereb Cortex"},{"key":"BFnpp2008227_CR62","first-page":"200","volume":"58","author":"M Rutkowska","year":"2006","unstructured":"Rutkowska M, Jamontt J, Gliniak H (2006). Effects of cannabinoids on the anxiety-like response in mice. Pharmacol Rep 58: 200\u2013206.","journal-title":"Pharmacol Rep"},{"key":"BFnpp2008227_CR63","doi-asserted-by":"publisher","first-page":"R1774","DOI":"10.1152\/ajpregu.00815.2004","volume":"288","author":"A Sapirstein","year":"2005","unstructured":"Sapirstein A, Saito H, Texel SJ, Samad TA, O\u2019Leary E, Bonventre JV (2005). Cytosolic phospholipase A2\u03b1 regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation. Am J Physiol Regul Integr Comp Physiol 288: R1774\u2013R1782.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFnpp2008227_CR64","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.pnpbp.2005.03.013","volume":"29","author":"A Serretti","year":"2005","unstructured":"Serretti A, Benedetti F, Zanardi R, Smeraldi E (2005). The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry 29: 1074\u20131084.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2008227_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.1990.tb08813.x","volume":"55","author":"T Shimizu","year":"1990","unstructured":"Shimizu T, Wolfe LS (1990). Arachidonic acid cascade and signal transduction. J Neurochem 55: 1\u201315.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1023\/A:1022534709672","volume":"24","author":"L Sokoloff","year":"1999","unstructured":"Sokoloff L (1999). Energetics of functional activation in neural tissues. Neurochem Res 24: 321\u2013329.","journal-title":"Neurochem Res"},{"key":"BFnpp2008227_CR67","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1016\/S0024-3205(02)02138-0","volume":"71","author":"C Stenfors","year":"2002","unstructured":"Stenfors C, Ross SB (2002). Evidence for involvement of 5-hydroxytryptamine1B autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life Sci 71: 2867\u20132880.","journal-title":"Life Sci"},{"key":"BFnpp2008227_CR68","first-page":"184","volume-title":"Computer-assisted research design and analysis","author":"BG Tabachnick","year":"2001","unstructured":"Tabachnick BG, Fidell LS (2001). Computer-assisted research design and analysis. Allyn and Bacon: Boston (novol), pp 184\u2013188."},{"key":"BFnpp2008227_CR69","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1046\/j.1471-4159.1999.0730684.x","volume":"73","author":"M Toborek","year":"1999","unstructured":"Toborek M, Malecki A, Garrido R, Mattson MP, Hennig B, Young B (1999). Arachidonic acid-induced oxidative injury to cultured spinal cord neurons. J Neurochem 73: 684\u2013692.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.mp.4002067","volume":"13","author":"R Uher","year":"2008","unstructured":"Uher R, McGuffin P (2008). The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13: 131\u2013146.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2008227_CR71","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/hmg\/ddm343","volume":"17","author":"JR Wendland","year":"2008","unstructured":"Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR et al (2008). A novel, putative gain-of-function haplotype at Slc6a4 associates with obsessive-compulsive disorder. Hum Mol Genet 17: 717\u2013723.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2008227_CR72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(24)36840-5","volume":"282","author":"DL Willins","year":"1997","unstructured":"Willins DL, Meltzer HY (1997). Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282: 699\u2013706.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008227_CR73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1046\/j.1471-4159.2002.01145.x","volume":"83","author":"J Xu","year":"2002","unstructured":"Xu J, Weng YI, Simonyi A, Krugh BW, Liao Z, Weisman GA et al (2002). Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J Neurochem 83: 259\u2013270.","journal-title":"J Neurochem"},{"key":"BFnpp2008227_CR74","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1074\/jbc.M705709200","volume":"283","author":"L Xu","year":"2008","unstructured":"Xu L, Han C, Lim K, Wu T (2008). Activation of cytosolic phospholipase A2\u03b1 through nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2. J Biol Chem 283: 3077\u20133087.","journal-title":"J Biol Chem"},{"key":"BFnpp2008227_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0090-6980(01)00177-0","volume":"67","author":"J Zhang","year":"2002","unstructured":"Zhang J, Goorha S, Raghow R, Ballou LR (2002). The tissue-specific, compensatory expression of cyclooxygenase-1 and -2 in transgenic mice. Prostaglandins Other Lipid Mediat 67: 121\u2013135.","journal-title":"Prostaglandins Other Lipid Mediat"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2008227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008227","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T23:09:55Z","timestamp":1738883395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2008227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,14]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFnpp2008227"],"URL":"https:\/\/doi.org\/10.1038\/npp.2008.227","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,14]]}}}